Volume Alert - JNJ 108.39 Johnson & Johnson $JNJ Hit a high

New Post Public Reply Private Reply Replies (0) Message Board

Nov 17, 2014 at 2:08 PM

Volume Alert - JNJ 108.39 Johnson & Johnson $JNJ Hit a high today of 108.69 Closing the day 10:30 at 108.39 +0.23 +0.21% With a day low of 107.61 and a total volume of 1,087,101.

JNJ Recent Posts: http://investorshangout.com/Johnson--Johnson-JNJ-51518/

JNJ Johnson & Johnson Recent Headline News

DexCom Still A Favorite Diabetes Stock
Bill Gunderson - at Seeking Alpha - 2 hrs 52 mins ago
DexCom (NASDAQ: DXCM ) continues to be one of my favorite diabetes stocks. DexCom, founded in 1999 and based right here in my hometown of San Diego, California, is a medical device company that makes continuous glucose monitoring (CGM) systems. ...
JNJ: 108.34 (+0.18), ABT: 43.84 (+0.03), DXCM: 52.03 (-0.70), MDT: 69.52 (+0.57)

Early Glance: Medical Devices companies
AP - Mon Nov 17, 9:29AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.62 (+0.50), JNJ: 108.34 (+0.18), MDT: 69.52 (+0.57), BAX: 71.97 (+0.22)

Early Glance: Pharmaceuticals companies
AP - Mon Nov 17, 9:29AM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 108.34 (+0.18), BAX: 71.97 (+0.22), PFE: 30.31 (-0.03), BMY: 58.40 (+0.45)

5 Rocket Stocks to Buy as Earnings Season Ends: Southwest Airlines and More
at The Street - Mon Nov 17, 9:17AM CST
From a momentum standpoint, stocks are well-positioned to keep up their upside action as we head into the final stretch of 2014.
JNJ: 108.34 (+0.18), ORLY: 177.17 (-2.71), ED: 62.54 (+0.51), LUV: 39.33 (+0.38), CRM: 62.67 (-1.24)

Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
George Budwell, The Motley Fool - Motley Fool - Mon Nov 17, 7:13AM CST
As the healthcare sector rolls through its third-quarter earnings, a bucolic picture is coming into focus. Earnings across the sector are soaring due to new drug launches, a frenzy of acquisitions, and vast reorganizations that have helped to stem...
JNJ: 108.34 (+0.18), GILD: 100.39 (-1.67), ABBV: 65.09 (+1.09), CELG: 104.48 (+0.43)

Forget Marijuana! This Is a Much Smarter Investment
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 16, 11:11AM CST
Source: Flickr user Oswaldo. Although marijuana initiatives didn't log a perfect sweep in this year's midterm elections, the momentum behind the legalization movement remains intact. Two states (Oregon and Alaska), as well as Washington, D.C.,...
JNJ: 108.34 (+0.18), INSY: 38.15 (-0.42), GWPH: 75.35 (-0.28), GSK: 45.86 (+0.12), NVS: 94.50 (+0.55)

Value Investors' Most Loved Stocks In Q3 2014
Trading Mates Stock Advisor - at Seeking Alpha - Sun Nov 16, 8:09AM CST

NOV: 71.78 (+0.44), JNJ: 108.34 (+0.18), IBM: 164.69 (+0.53), WMT: 83.54 (+0.58), BAC: 17.08 (-0.06), BEN: 56.32 (-0.06), ACN: 84.58 (-0.06), SLB: 96.26 (+0.94), ORCL: 41.18 (+0.34)

3 Ways High-Yield Dividend Stocks Can Help You Recreate Warren Buffett's Investing Success
Adam Galas, The Motley Fool - Motley Fool - Sat Nov 15, 6:05PM CST
Many people consider Warren Buffett the greatest investor in history and it's not hard to understand why. According to a 2012 Yale study, Buffett's company, Berkshire Hathaway , had the best risk-adjusted return of any company or mutual fund that...
KMI: 40.10 (+0.73), MMM: 158.99 (+0.14), JNJ: 108.34 (+0.18), LNCO: 20.31 (-0.62), IBM: 164.69 (+0.53), WFC: 53.40 (+0.05), SDRL: 20.93 (+0.15), PG: 87.68 (-0.43), LINE: 22.34 (-0.31), VNR: 24.03 (-0.45), CL: 67.80 (+0.24)

Johnson & Johnson Part VI: 'Magic Pants' And 'Doubling Pennies'
Robert Honeywill - Seeking Alpha - Sat Nov 15, 6:00AM CST
In Part V of this series, I provided 4 scenarios (8 Cases) illustrating the potential financial outcomes for investors in Johnson & Johnson (NYSE: JNJ ) under changing PE ratios, which are a reflection of changing share prices and changing...
JNJ: 108.34 (+0.18)

Retirement Strategy: Annuities Vs. Dividend Growth Investing For A Lifetime Income
Regarded Solutions - at Seeking Alpha - Fri Nov 14, 11:01PM CST

KO: 42.86 (+0.13), T: 35.85 (-0.05), JNJ: 108.34 (+0.18), GE: 26.63 (+0.17), XOM: 94.83 (-0.26), MCD: 95.81 (-0.40), PG: 87.68 (-0.43), CVX: 115.91 (-0.41), AAPL: 113.90 (-0.28), WAG: 66.30 (-0.63)

Final Glance: Pharmaceuticals companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 108.34 (+0.18), BAX: 71.97 (+0.22), PFE: 30.31 (-0.03), BMY: 58.40 (+0.45)

Final Glance: Medical Devices companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.62 (+0.50), JNJ: 108.34 (+0.18), MDT: 69.52 (+0.57), BAX: 71.97 (+0.22)

Geron Collaborates with J&J for Imetelstat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:00PM CST
Geron Corporation (GERN), a clinical-stage biopharmaceutical company, announced that it has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc., a unit of Johnson & Johnson (JNJ).
BIIB: 304.41 (-1.02), JNJ: 108.34 (+0.18), GERN: 3.00 (+0.24), AFFX: 9.27 (-0.44)

Halliburton and Geron are big market movers
AP - Fri Nov 14, 3:29PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
SINA: 39.51 (-0.29), AMZN: 321.91 (-5.91), JNJ: 108.34 (+0.18), HTZ: 22.10 (+0.41), GERN: 3.00 (+0.24), HAL: 49.59 (-5.49), JWN: 73.22 (-0.95), NOK: 7.67 (-0.19), BHI: 66.06 (+6.17)

Geron's Short Squeeze Is Here
Vahan Avetisyan - Seeking Alpha - Fri Nov 14, 2:40PM CST
Geron' s 2014 D eal to the Rescue Geron (NASDAQ: GERN ) surprised Thursday after-hours when it announced news that it entered into an exclusive worldwide license and collaboration agreement to develop its blood disorder drug imetelstat with...
JNJ: 108.34 (+0.18), GERN: 3.00 (+0.24)

Mallinckrodt Shares Down on Setback for Generic Concerta - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:39PM CST
Mallinckrodt (MNK) received a setback when the FDA informed the company that its methylphenidate hydrochloride extended-release tablets, USP (CII) might not be therapeutically equivalent to Johnson & Johnson's (JNJ) Concerta.
MNK: 88.04 (-0.07), BIIB: 304.41 (-1.02), JNJ: 108.34 (+0.18), ACT: 247.01 (+3.24)

Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline
at The Street - Fri Nov 14, 2:36PM CST
U.S. stocks fluctuate on Friday, caught between better-than-expected retail sales and more worries of eurozone deflation.
SINA: 39.51 (-0.29), JNJ: 108.34 (+0.18), HTZ: 22.10 (+0.41), VA: 30.86 (+0.86), GERN: 3.00 (+0.24), JWN: 73.22 (-0.95)

Midday Glance: Pharmaceuticals companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
JNJ: 108.34 (+0.18), BAX: 71.97 (+0.22), PFE: 30.30 (-0.04), BMY: 58.40 (+0.45)

Midday Glance: Medical Devices companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.62 (+0.50), JNJ: 108.34 (+0.18), MDT: 69.52 (+0.57), BAX: 71.97 (+0.22)

Johnson & Johnson (JNJ) Stock Research Links

JNJ Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sustainability 2026: Action Beyond Conference Halls

Carbon-Neutral Promises: Walking the Walk Forget endless talk—Shanghai's 2026 Sustainability Global Leaders Conference hammered home that actions need to spill over beyond the plush conference seats every single attendee warmed. We're not talking about token efforts either; they ensured the gathering itself was carbon-neutral. That's practicing what you preach with a...

Bram Schot Steers Marelli Through Chapter 11 Resurgence

So, Marelli's rolling out the heavy artillery with the appointment of Bram Schot as their future Chair. This isn't just reshuffling a few chairs on the deck of a wobbly ship. No, Marelli's emergence from Chapter 11, with Schot at the helm, is more akin to a full-blown course correction. The man comes seasoned, having braved the corporate gales at Audi, Mercedes-Benz, and...

Jury Awards $29M in Landmark School Abuse Case

California Schools Face Scrutiny Over Abuse Verdict Some days, the gavel falls, and its echo shakes up more than just a courtroom. That’s exactly what we’re seeing with this hefty $29 million verdict against ABC Unified School District. It’s not just a payout; it’s a bombshell that could change the landscape for how schools handle allegations of abuse. $29 Million...

CorelDRAW PowerTRACE: Fast, Precise Vector Conversion

Expert Consumers Spotlight CorelDRAW PowerTRACE Ah, the humble art of converting blurry bitmaps into crisp vectors—a task plenty have fumbled through with countless late nights and missed deadlines. But here's a kicker: CorelDRAW PowerTRACE seems to be setting new standards in bitmap-to-vector conversions this year, grabbing attention with some pretty spiffy upgrades...

Ast?'s Strategy: Scaling Brands with Operator Insight

Defining the Investor-Entrepreneur Partnership Ah, building a consumer brand is no walk in the park, but what about scaling it? Here's where the rubber really meets the road. Enter Ast? Consumer Partners, a firm that clearly understands that scaling a brand isn't all about throwing cash at it—it’s about precision and the right mix of wisdom, much like a seasoned chef...

Key Life Events That Demand a Financial Plan Change

Navigating Life's Milestones with Financial Savvy Nothing stirs the financial pot quite like life's big events. The grind of daily life might trick you into thinking everything's fine, but ignore these milestones at your peril. Ted Thatcher, a financial advisor from Roseville, California, lays it out in HelloNation's latest foray into sound financial planning: your...

Qfin Faces Stock Lawsuit: Know Your Investor Rights

Qfin in the Legal Hot Seat When you hear about a company's legal wranglings, especially one like Qfin Holdings, Inc., you've got to sit up and take notice. We're not talking about a quick scuffle here; this is a full-blown class action lawsuit with its talons sunk deep into allegations of securities law violations. They're squared off against DJS Law Group, an outfit that...

GAC Hits Record with 223,000 Units Exported in 2026

GAC Gaining Ground Globally in 2026 China's GAC is making waves with its recent export figures. They've blitzed past the competition, exporting 223,000 units from January to October 2026. That's not just a number, it’s a record, with October alone seeing a hefty 26,017 units shipped—marking an impressive 80.8% growth compared to last year. A Strategic Push in Europe...

Aries Ignites a Social Renaissance in La Jolla

The Dawn of Aries: A Beacon for Social Change Coming out of nowhere, Aries is set to make waves in La Jolla, and no, I'm not talking about another swell hitting the shores. Instead, we're witnessing a new chapter for the rooftop of Hotel La Jolla, where an investment of over a cool million bucks aims to deliver a slice of European flare right here on the Pacific. A...

'Dedicate' Series Arrives on Prime, Tapping Global Heartstrings

An Unconventional Hit Finds a New Home Kick back for a second, because this ain't just another series buried under the deluge of shows streaming these days. Nope, this is about 'Dedicate,' a joint of its own unique flavor that's now nabbed a spot on Prime Video. It's not like we're talking about the latest Hollywood blockbuster here—it's a series brought to you by The...